Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is a very rare and highly aggressive cancer of the pleura associated in most cases with asbestos exposure. To date, no really efficient treatments are available for this pathology. Recently, it has been shown that epigenetic drugs, particularly DNA me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Epigenetics
Hauptverfasser: Bensaid, Douae, Blondy, Thibaut, Deshayes, Sophie, Dehame, Virginie, Bertrand, Philippe, Grégoire, Marc, Errami, Mohammed, Blanquart, Christophe
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2018
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006850/
https://ncbi.nlm.nih.gov/pubmed/29946373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0517-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge